227 related articles for article (PubMed ID: 14742769)
41. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.
Slovik DM; Rosenthal DI; Doppelt SH; Potts JT; Daly MA; Campbell JA; Neer RM
J Bone Miner Res; 1986 Aug; 1(4):377-81. PubMed ID: 3503551
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics of oral recombinant human parathyroid hormone [rhPTH(1-31)NH₂] in postmenopausal women with osteoporosis.
Sturmer A; Mehta N; Giacchi J; Cagatay T; Tavakkol R; Mitta S; Fitzpatrick L; Wald J; Trang J; Stern W
Clin Pharmacokinet; 2013 Nov; 52(11):995-1004. PubMed ID: 23719683
[TBL] [Abstract][Full Text] [Related]
43. Teriparatide (forteo) for osteoporsis.
Med Lett Drugs Ther; 2003 Feb; 45(1149):9-10. PubMed ID: 12571538
[No Abstract] [Full Text] [Related]
44. Safety of osteoanabolic therapy: a decade of experience.
Cipriani C; Irani D; Bilezikian JP
J Bone Miner Res; 2012 Dec; 27(12):2419-28. PubMed ID: 23165426
[No Abstract] [Full Text] [Related]
45. Nitroglycerin ointment for the prevention of postmenopausal osteoporosis.
Beckett RD; Sheehan AH
Ann Pharmacother; 2011 Dec; 45(12):1566-70. PubMed ID: 22009995
[TBL] [Abstract][Full Text] [Related]
46. Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report.
Nishikawa A; Ishida T; Taketsuna M; Yoshiki F; Enomoto H
Clin Interv Aging; 2016; 11():913-25. PubMed ID: 27462147
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis.
Satterwhite J; Heathman M; Miller PD; Marín F; Glass EV; Dobnig H
Calcif Tissue Int; 2010 Dec; 87(6):485-92. PubMed ID: 20953593
[TBL] [Abstract][Full Text] [Related]
48. Fracture Risk Following Discontinuation of Teriparatide: A Review of the Literature.
Murphy PZ; Iranikhah M; Deas CM; Freeman MK
Consult Pharm; 2018 Jul; 33(7):365-375. PubMed ID: 29996965
[TBL] [Abstract][Full Text] [Related]
49. Teriparatide in patients with osteoporosis and type 2 diabetes.
Schwartz AV; Pavo I; Alam J; Disch DP; Schuster D; Harris JM; Krege JH
Bone; 2016 Oct; 91():152-8. PubMed ID: 27374026
[TBL] [Abstract][Full Text] [Related]
50. [New medication for osteoporosis. To further increase instead of braking reduction].
MMW Fortschr Med; 2003 Oct; 145(44):44. PubMed ID: 14655508
[No Abstract] [Full Text] [Related]
51. [A new osteoporosis drug. Recombinant parathyroid hormone rebuilds bone].
MMW Fortschr Med; 2003 Jun; 145(25):53. PubMed ID: 12891857
[No Abstract] [Full Text] [Related]
52. Safety of parathyroid hormone for the treatment of osteoporosis.
Miller PD
Curr Osteoporos Rep; 2008 Mar; 6(1):12-6. PubMed ID: 18430395
[TBL] [Abstract][Full Text] [Related]
53. Teriparatide: a review of its use in osteoporosis.
Blick SK; Dhillon S; Keam SJ
Drugs; 2008; 68(18):2709-37. PubMed ID: 19093708
[TBL] [Abstract][Full Text] [Related]
54. Patient willingness to take teriparatide.
Fraenkel L; Gulanski B; Wittink D
Patient Educ Couns; 2007 Feb; 65(2):237-44. PubMed ID: 16965888
[TBL] [Abstract][Full Text] [Related]
55. [Update and perspectives of anabolic therapies for osteoporosis].
Endo I; Matsumoto T
Clin Calcium; 2012 Mar; 22(3):327-33. PubMed ID: 22370299
[TBL] [Abstract][Full Text] [Related]
56. The first biosimilar approved for the treatment of osteoporosis: results of a comparative pharmacokinetic/pharmacodynamic study.
Takács I; Jókai E; Kováts DE; Aradi I
Osteoporos Int; 2019 Mar; 30(3):675-683. PubMed ID: 30357438
[TBL] [Abstract][Full Text] [Related]
57. Impressive results of teriparatide treatment of postgastrectomy osteoporosis.
Bacun T; Kibel A; Pavić R
Med Glas (Zenica); 2011 Aug; 8(2):305-8. PubMed ID: 21849961
[TBL] [Abstract][Full Text] [Related]
58. Recombinant hormones in osteoporosis.
Rejnmark L
Expert Opin Biol Ther; 2013 Aug; 13(8):1135-47. PubMed ID: 23646915
[TBL] [Abstract][Full Text] [Related]
59. Clinical update on teriparatide.
File E; Deal C
Curr Rheumatol Rep; 2009 Jul; 11(3):169-76. PubMed ID: 19604460
[TBL] [Abstract][Full Text] [Related]
60. Osteoporosis and asthma.
Kearney DM; Lockey RF
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):769-74; quiz 775-8, 857. PubMed ID: 16802763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
